First Trimester Aneuploidy Screening: Nuchal Translucency Scan and Cell-Free DNA (NIPT)

First Trimester Aneuploidy Screening: Nuchal Translucency Scan and Cell-Free DNA (NIPT)

Detecting Trisomy 21, 18, 13, and major structural abnormalities between 11-13 weeks with over 99% clinical accuracy.

1. Core Clinical Evidence

During pregnancy, profound endocrine transformations and accelerated fetal embryogenesis require careful adherence to evidence-based healthcare standards. Always consult your obstetrician for individualized medical guidance.

• Maintain a nutritionally balanced diet rich in micronutrients and clean hydration.
• Attend all scheduled prenatal screening visits and ultrasound scans.
• Listen to your body and report any red flag symptoms promptly to triage.

2. Expert Obstetric Recommendations

Prioritizing mental well-being, adequate sleep hygiene, and daily hydration forms the cornerstone of healthy fetal development and safe maternal transition.